ABI, Caprion, Berlex, Novo Nordisk, Ciphergen, Nasdaq, GE Healthcare, Manipal AcuNova, Thermo, Clinical Data, Johns Hopkins | GenomeWeb

ABI Reports 4-Percent Revenue Growth in Fiscal Q2; Mass Spec Sales Grow 5 Percent

Applied Biosystems reported a 4-percent increase in total revenue for its second quarter of fiscal 2006, the company said this week.

ABI had total revenues of $481 million for the three months ended Dec. 31, 2005, compared to $463 million for same period one year ago. Revenue for its mass spectrometry segment grew 5 percent to $119 million year over year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.